Clinical trial
Study of TNF-Antagonism in the Metabolic Syndrome (II)
NCT00413400 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00413400 |
|---|---|
| Title | Study of TNF-Antagonism in the Metabolic Syndrome (II) |
| Official title | Effects of Etanercept in Patients With the Metabolic Syndrome (II) |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Amgen Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Metabolic Syndrome |
| Intervention type | Drug |
| Interventions | Etanercept, Placebo |
| Enrollment | 40 |
| Start date | Dec 1, 2006 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Dec 19, 2006 |
| Last update posted | Dec 2, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: